findmyKOL

David Sarraf, MD

Basic profile

VA Greater Los Angeles Healthcare System

ORCIDNPI
RegionLos Angeles, CA · WestSpecialtyOphthalmologyFocusOphthalmology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

David Sarraf is an Ophthalmology physician affiliated with VA Greater Los Angeles Healthcare System. OpenAlex indexes 592 publications with 21,148 citations (h-index 56). By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
592publications

Distinct works indexed by OpenAlex, matched via ORCID.

21,148citations

Total citations across indexed works.

56h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

100 Stein Plaza
Rm 1-340
Los Angeles, CA 90095

Telephone

310-825-5000

Registry record last updated 22 Dec 2010.

View the NPPES registry record

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    52.2%
    Mast Cell Stabilizer52.2%
    Olopatadine Hcl100%
    Part D<11 patients
  • Cancer & immunology

    47.8%
    Calcineurin inhibitor47.8%
    Restasis100%
    Part D<11 patients
Where care is delivered (Part B)17.1% facility · 82.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”